Abstract
Background and aims
Metronidazole, a commonly used antibiotic drug, can cause adverse effects in the central nervous system termed metronidazole-induced encephalopathy, leading to diagnostic challenges. The condition is rare and a detailed description of its phenotype is lacking. In this systematic review we investigated the clinical features of metronidazole-induced encephalopathy to promote recognition and elaborate the description.
Methods
We performed a systematic literature search using PubMed.gov and hand searched the reference lists of included articles and other publications of interest. We included case series and single reports describing individual patients developing symptoms from the central nervous system in relation to metronidazole treatment. Data were extracted and analyzed descriptively.
Results
We identified 779 publications of which 112 papers comprising 136 patients were included. Typical findings were dysarthria, gait instability, limb dyscoordination and altered mental status. Frequently, patients concomitantly presented with metronidazole-induced polyneuropathy. Liver disease was the most common pre-existing condition. MRI showed a characteristic pattern of reversible symmetrical hyperintense lesions on T2/FLAIR of the dentate nuclei in 90% of patients. Most patients improved significantly after discontinuation of metronidazole. Poor outcome was associated with severe comorbidity.
Conclusion
Metronidazole-induced encephalopathy should be considered in patients presenting with neurological symptoms in relation to newly initiated or prolonged metronidazole treatment. MRI changes are highly characteristic and specific. Patients with liver disease are at increased risk. Prognosis is good if recognized early.
Similar content being viewed by others
Abbreviations
- *:
-
Denotes patients for whom polyneuropathy presented before CNS symptoms
- +PNS:
-
Remaining symptoms of polyneuropathy at follow-up
- CC:
-
Corpus callosum
- CNS:
-
Central nervous system
- COPD:
-
Chronic obstructive pulmonary disease
- CWM:
-
Cerebral white matter
- DIC:
-
Disseminated intravascular coagulation
- DM:
-
Diabetes mellitus
- DN:
-
Dentate nuclei
- MB:
-
Midbrain
- MBD :
-
Dorsal midbrain
- MBRN :
-
Midbrain with involvement of the red nuclei
- MO:
-
Medulla oblongata
- MOION :
-
Medulla oblongata with involvement of the inferior olivary nuclei
- N/R:
-
Not reported
References
Klein EY et al (2018) Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci USA 115(15):E3463–E3470
Morgan DJ et al (2011) Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect Dis 11(9):692–701
Bhattacharyya S et al (2016) Antibiotic-associated encephalopathy. Neurology 86(10):963–971
Lofmark S, Edlund C, Nord CE (2010) Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis 50(Suppl 1):S16–S23
Goolsby TA, Jakeman B, Gaynes RP (2018) Clinical relevance of metronidazole and peripheral neuropathy: a systematic review of the literature. Int J Antimicrob Agents 51(3):319–325
Liberati A et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6(7):e1000100
Agah E et al (2017) Metronidazole-induced neurotoxicity presenting with sudden bilateral hearing loss, encephalopathy, and cerebellar dysfunction. Eur J Clin Pharmacol 73(2):249–250
Agarwal A et al (2016) Metronidazole-Induced Cerebellar Tox. Neurol Int 8(1):6365
Ahmed A, Loes DJ, Bressler EL (1995) Reversible magnetic resonance imaging findings in metronidazole-induced encephalopathy. Neurology 45(3 Pt 1):588–589
AlDhaleei W, AlMarzooqi A, Gaber N (2018) Reversible metronidazole-induced neurotoxicity after 10 weeks of therapy. BMJ Case Rep. https://doi.org/10.1136/bcr-2017-223463
Alvarez RS et al (1983) Central nervous system toxicity related to prolonged metronidazole therapy. Am J Obstet Gynecol 145(5):640–641
Arik N, Cengiz N, Bilge A (2001) Metronidazole-induced encephalopathy in a uremic patient: a case report. Nephron 89(1):108–109
Bae EH et al (2016) Metronidazole-Induced Encephalopathy: a case report. J Nippon Med Sch 83(2):44–45
Bahn Y et al (2010) Metronidazole induced encephalopathy in a patient with brain abscess. J Korean Neurosurg Soc 48(3):301–304
Bailes J et al (1983) Encephalopathy with metronidazole in a child. Am J Dis Child 137(3):290–291
Bates JE, Almast J, Augustine EF (2015) Neonatal dentate nucleus T2 hyperintensity after in utero metronidazole exposure. Neurology 85(11):1006
Beloosesky Y et al (2000) Convulsions induced by metronidazole treatment for Clostridium difficile-associated disease in chronic renal failure. Am J Med Sci 319(5):338–339
Bonda C, Evans MS (2015) Metronidazole CNS toxicity. Acta Neurol Belg 115(4):709–710
Bonkowsky JL, Sondrup C, Benedict SL (2007) Acute reversible cerebellar lesions associated with metronidazole therapy. Neurology 68(3):180
Bottenberg MM et al (2011) Metronidazole-induced encephalopathy: a case report and review of the literature. J Clin Pharmacol 51(1):112–116
Cacao G et al (2015) Metronidazole-induced central and peripheral nervous system toxicity. Neurol Sci 36(9):1737–1739
Cantador AA et al (2013) Nonconvulsive status with metronidazole. Neurohospitalist 3(4):185–189
Cecil KM et al (2002) Reversible MR imaging and MR spectroscopy abnormalities in association with metronidazole therapy. J Comput Assist Tomogr 26(6):948–951
Chacko J et al (2011) Clinical, neuroimaging and pathological features of 5-nitroimidazole-induced encephalo-neuropathy in two patients: Insights into possible pathogenesis. Neurol India 59(5):743–747
Chakrabarti S, Pan K (2014) Metronidazole-induced encephalopathy: an uncommon scenario. N Z Med J 127(1393):120–122
Chandak S et al (2016) A case report of metronidazole induced neurotoxicity in liver abscess patient and the usefulness of MRI for its diagnosis. J Clin Diagn Res 10(1):TD06–T7
Chatzkel JA, Vossough A (2010) Metronidazole-induced cerebellar toxicity. Pediatr Radiol 40(8):1453
Chaudhari TS, Malhotra HS, Garg RK (2014) Face of the giant panda with bright eyes in metronidazole neurotoxicity. Neurol India 62(2):212–213
Cheong HC et al (2011) Metronidazole-induced encephalopathy in a patient with liver cirrhosis. Korean J Hepatol 17(2):157–160
Clements A (2017) Case report of metronidazole-induced encephalopathy. WMJ 116(5):221–223
De Bleecker JL, Leroy BP, Meire VI (2005) Reversible visual deficit and Corpus callosum lesions due to metronidazole toxicity. Eur Neurol 53(2):93–95
Deenadayalu VP et al (2005) Abnormal enhancing lesion of dentate nuclei causing neurologic symptoms induced by metronidazole toxicity. Clin Gastroenterol Hepatol 3(3):xxix
Demel SL, Jovin TG, Jadhav AP (2015) Metronidazole toxicity presenting with acute onset of aphasia and right sided weakness. J Clin Neurosci 22(7):1199–1200
Desai JA et al (2011) Metronidazole-induced encephalopathy: case report and review of MRI findings. Can J Neurol Sci 38(3):512–513
Dhar A et al (2016) Mystery case: metronidazole-induced encephalopathy. Neurology 87(9):e89–e90
Erdener SE et al (2013) Brain MRI evolution of metronidazole intoxication. Neurology 80(19):1816–1817
Eren F et al (2017) A case with reversible neurotoxicity induced by metronidazole. Ideggyogy Szem 70(11–12):429–432
Etxeberria A et al (2012) Metronidazole-cerebellopathy associated with peripheral neuropathy, downbeat nystagmus, and bilateral ocular abduction deficit. Rev Neurol (Paris) 168(2):193–195
Farmakiotis D, Zeluff B (2016) Images in clinical medicine. Metronidazole-associated encephalopathy. N Engl J Med 374(15):1465
Foreid H et al. (2009) Reversible iatrogenic subacute cerebellar syndrome, myoclonus and MRI findings following metronidazole administration. BMJ Case Rep
Frytak S, Moertel CH, Childs DS (1978) Neurologic toxicity associated with high-dose metronidazole therapy. Ann Intern Med 88(3):361–362
Furukawa S et al (2015) Metronidazole-induced encephalopathy with contrast enhancing lesions on MRI. J Neurol Sci 352(1–2):129–131
Galvez M, Brahm J, Miranda M (2009) Movement disorders as a manifestation of metronidazole-induced encephalopathy in a patient with chronic liver disease. Mov Disord 24(12):1864–1866
Godfrey MS, Finn A, Zainah H, Dapaah-Afriyie K (2015) Metronidazole-induced encephalopathy after prolonged metronidazole course for treatment of C. difficile colitis. BMJ Case Rep. https://doi.org/10.1136/bcr-2014-206162
Graves TD et al (2009) Reversible metronidazole-induced cerebellar toxicity in a multiple transplant recipient. J Neurol Sci 285(1–2):238–240
Groothoff MV et al (2010) Irreversible encephalopathy after treatment with high-dose intravenous metronidazole. Clin Ther 32(1):60–64
Gupta AK et al (2003) Metrondazole-induced neurotoxicity. J Assoc Physicians India 51:617–618
Halloran TJ (1982) Convulsions associated with high cumulative doses of metronidazole. Drug Intell Clin Pharm 16(5):409
Hammami N et al (2007) Reversible metronidazole-induced encephalopathy. J Neuroradiol 34(2):133–136
Hanji Y et al (2017) Metronidazole-induced encephalopathy associated with treatment for liver abscesses. J Gen Fam Med 18(5):265–267
Hari A, Srikanth BA, Lakshmi GS (2013) Metronidazole induced cerebellar ataxia. Indian J Pharmacol 45(3):295–297
Haridas A et al (2015) Metronidazole-Induced Encephalopathy in Chronic Diarrhoea. J Assoc Physicians India 63(6):77–79
Heaney CJ, Campeau NG, Lindell EP (2003) MR imaging and diffusion-weighted imaging changes in metronidazole (Flagyl)-induced cerebellar toxicity. AJNR Am J Neuroradiol 24(8):1615–1617
Higashi M et al (2013) Metronidazole-induced encephalopathy. Intern Med 52(7):843–844
Hobbs K et al (2015) Metronidazole-induced encephalopathy: not always a reversible situation. Neurocrit Care 22(3):429–436
Horlen CK, Seifert CF, Malouf CS (2000) Toxic metronidazole-induced MRI changes. Ann Pharmacother 34(11):1273–1275
Huang YT, Chen LA, Cheng SJ (2012) Metronidazole-induced encephalopathy: case report and review literature. Acta Neurol Taiwan 21(2):74–78
Hwang GH et al (2012) Metronidazole induced encephalopathy with peripheral polyneuropathy in patient with spinal cord injury. Korean J Spine 9(1):44–48
Iqbal A et al (2013) Clinical and imaging perspective and unanswered questions in a case of metronidazole induced encephalopathy. Ann Indian Acad Neurol 16(4):569–571
Ito H et al (2004) Reversible cerebellar lesions induced by metronidazole therapy for helicobacter pylori. J Neuroimaging 14(4):369–371
Iwadate D et al (2017) Thiamine deficiency in metronidazole-induced encephalopathy: a metabolic correlation? J Neurol Sci 379:324–326
Jang HJ et al (2012) Atypical metronidazole-induced encephalopathy in anaerobic brain abscess. J Korean Neurosurg Soc 52(3):273–276
Kafadar I et al (2013) A rare adverse effect of metronidazole: nervous system symptoms. Pediatr Emerg Care 29(6):751–752
Kalia V, Vibhuti, Saggar K (2010) Case report: MRI of the brain in metronidazole toxicity. Indian J Radiol Imaging 20(3):195–197
Khodakaram K, Barmano N (2011) Uncommon reaction to a common prescription. Lancet 378(9787):288
Kim DW et al (2004) Metronidazole-induced encephalopathy. J Neurol Sci 224(1–2):107–111
Kim E et al (2007) MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings. AJNR Am J Neuroradiol 28(9):1652–1658
Kim H et al (2011) Metronidazole-induced encephalopathy in a patient with infectious colitis: a case report. J Med Case Rep 5:63
Kim J et al (2017) Metronidazole-induced encephalopathy in a patient with Crohn’s disease. Intest Res 15(1):124–129
Kim SM et al (2011) Serially changing metronidazole-induced encephalopathy. Can J Neurol Sci 38(6):921–924
Knorr JP et al (2012) Metronidazole-induced encephalopathy in a patient with end-stage liver disease. Case Reports Hepatol 2012:209258
Kumari P et al (2016) Metronidazole induced neurotoxicity in a case of liver abscess. Int J Hepatobiliary Pancreat Dis 6:96–99
Kuriyama A (2017) Chestnut sign: metronidazole-induced encephalopathy. J Emerg Med 52(1):101–102
Kuriyama A et al (2011) Metronidazole-induced central nervous system toxicity: a systematic review. Clin Neuropharmacol 34(6):241–247
Kusumi RK et al (1980) Central nervous system toxicity associated with metronidazole therapy. Ann Intern Med 93(1):59–60
Lawford R, Sorrell TC (1994) Amebic abscess of the spleen complicated by metronidazole-induced neurotoxicity: case report. Clin Infect Dis 19(2):346–348
Lee HC, Kim YE, Ma HI (2017) Metronidazole-induced craniocervical myoclonus with reversible bilateral dentate nucleus lesions. J Mov Disord 10(1):67–68
Lee JH et al (2008) Metronidazole-induced toxic encephalopathy in a hemodialysis patient: a case report. Korean J Nephrol 27(6):743–746
Lee SS et al (2009) Reversible inferior colliculus lesion in metronidazole-induced encephalopathy: magnetic resonance findings on diffusion-weighted and fluid attenuated inversion recovery imaging. J Comput Assist Tomogr 33(2):305–308
Lefkowitz A, Shadowitz S (2018) Reversible cerebellar neurotoxicity induced by metronidazole. CMAJ 190(32):E961
McCabe J, Neale J, Varghese A (2017) A case of metronidazole-induced neurotoxicity. Postgrad Med J 93(1105):712
Mehndiratta MM, Pandey S, Nayak R (2013) Metronidazole encephalopathy. J Assoc Physicians India 61(7):485
Mittal GK et al (2017) Dentate hyperintensities—the imaging signature of metronidazole induced encephalopathy. J Neurosci Rural Pract 8(2):272–273
Mizuta K et al (2018) Metronidazole-induced encephalopathy in a patient with pyogenic spondylitis: a case report. BMC Musculoskelet Disord 19(1):336
Moosa AN, Perkins D (2010) Neurological picture. MRI of metronidazole induced cerebellar ataxia. J Neurol Neurosurg Psychiatry 81(7):754–755
Moriya M et al (2013) Reversible lesions of cerebellar dentate nuclei associated with metronidazole therapy. Neurol Clin Neurosci 1(6):227–228
Mulcahy H, Chaddha SK (2008) MRI of metronidazole-induced encephalopathy. Radiol Case Rep 3(4):239
Naqi R, Azeemuddin M, Beg MA (2012) Magnetic resonance imaging of metronidazole induced encephalopathy. J Pak Med Assoc 62(8):843–844
Ng PS, Saini M (2014) Reversible metronidazole-induced subacute cerebellar syndrome. QJM 107(12):1051–1052
Onuma Y et al (2017) Irreversible metronidazole encephalopathy in an elderly woman with primary biliary cholangitis. J Gen Fam Med 18(6):436–438
Papathanasiou A et al (2013) Metronidazole-induced reversible encephalopathy in a patient with facioscapulohumeral muscular dystrophy. Clin Neuroradiol 23(3):217–219
Park KI, Chung JM, Kim JY (2011) Metronidazole neurotoxicity: sequential neuroaxis involvement. Neurol India 59(1):104–107
Patel K et al (2008) Cerebellar ataxia following prolonged use of metronidazole: case report and literature review. Int J Infect Dis 12(6):e111–e114
Rizvi I et al (2018) Metronidazole-associated encephalopathy: a reversible condition. Intern Emerg Med 13(8):1323–1325
Roy U et al (2016) Clinical and neuroradiological spectrum of metronidazole induced encephalopathy: our experience and the review of literature. J Clin Diagn Res 10(6):OE01–O9
Sandip S, Afshan I, Khandelwal RK (2015) MR features of metronidazole-induced encephalopathy. BMJ Case Rep
Sarna JR, Brownell AK, Furtado S (2009) Cases: reversible cerebellar syndrome caused by metronidazole. CMAJ 181(9):611–613
Senthilkumaran S et al (2015) Metronidazole encephalopathy: uncommon reaction to a common drug. Int J Crit Illn Inj Sci 5(2):123–124
Seok JI et al (2003) Metronidazole-induced encephalopathy and inferior olivary hypertrophy: lesion analysis with diffusion-weighted imaging and apparent diffusion coefficient maps. Arch Neurol 60(12):1796–1800
Sevy A et al (2011) Central and peripheral neurotoxicity of metronidazole after treatment for brain abscess. Acta Neurochir (Wien) 153(12):2491–2492
Simonetta F, Christou F, Vandoni RE, Nierle T (2013) Walking unsteadily: a case of acute cerebellar ataxia. BMJ Case Rep. https://doi.org/10.1136/bcr-2012-007688
Singh R et al (2017) Sequential MR imaging (with diffusion-weighted imaging) changes in metronidazole-induced encephalopathy. Indian J Radiol Imaging 27(2):129–132
Sonthalia N et al (2016) Metronidazole-induced encephalopathy in alcoholic liver disease: a diagnostic and therapeutic challenge. J Emerg Med 51(4):e79–e83
Sørensen CG et al. (2018) Convulsive seizures as presenting symptom of metronidazole-induced encephalopathy: a case report. Case Rep Neurol 10(1):34–37
Sudan YS et al (2016) Headphone sign: Metronidazole-induced encephalopathy. Neurol India 64(6):1374–1376
Takada K et al (2018) Metronidazole Induced encephalopathy mimicking an acute ischemic stroke event. Neurol Med Chir (Tokyo) 58(9):400–403
Tan CH et al (2011) Painful neuropathy due to skin denervation after metronidazole-induced neurotoxicity. J Neurol Neurosurg Psychiatry 82(4):462–465
Taniyama D, Maruki T (2018) Metronidazole-associated encephalopathy. Am J Trop Med Hyg 98(2):351–352
Thakkar N et al (2016) Metronidazole Induced Encephalopathy. J Assoc Physicians India 64(11):72–74
Vitturi BK et al (2018) Metronidazole-induced encephalopathy. Rev Neurol (Paris) 174(5):342–343
Vivas LL et al (2016) An 82-year-old man with ataxia and dysarthria. CMAJ 188(17–18):1251–1254
Ward F, Crowley P, Cotter PE (2015) Acute cerebellar syndrome associated with metronidazole. Pract Neurol 15(4):298–299
Wienbren M et al (1985) Convulsions and encephalopathy in a patient with leukemia after treatment with metronidazole. J Clin Pathol 38(9):1076
Woodruff BK, Wijdicks EF, Marshall WF (2002) Reversible metronidazole-induced lesions of the cerebellar dentate nuclei. N Engl J Med 346(1):68–69
Yagi S, Matsumoto H, Hashida H (2018) Asymmetric magnetic resonance imaging findings in metronidazole-induced encephalopathy. Intern Med 57(13):1955–1956
Yagi T et al (2015) Metronidazole-induced encephalopathy and myoclonus: case report and a review of the literature. Neurol Clin Neurosci 3(3):111–113
Yamamoto T et al (2012) Metronidazole-induced neurotoxicity developed in liver cirrhosis. J Clin Med Res 4(4):295–298
Yui JC, Bonnes SL (2017) 74-Year-old woman with dysarthria and left lower extremity weakness. Mayo Clin Proc 92(6):973–977
de Souza A, Narvencar KP, Sindhoora KV (2013) The neurological effects of methyl bromide intoxication. J Neurol Sci 335(1–2):36–41
Gopinath KG et al (2015) Ornidazole-induced ataxia in an Indian woman: a case report. SAGE Open Med Case Rep 3:2050313 × 15621857
Taskapilioglu O et al (2010) Reversible cerebellar toxicity during treatment with ornidazole: the first case report. J Neurol Neurosurg Psychiatry 81(3):349–350
Bond KM et al (2017) Dentate update: imaging features of entities that affect the dentate nucleus. AJNR Am J Neuroradiol 38(8):1467–1474
Khadilkar S et al (2016) A practical approach to diseases affecting dentate nuclei. Clin Radiol 71(1):107–119
Dainer MJ (1979) Untoward reaction to Flagyl (metronidazole). Am J Obstet Gynecol 133(8):939–940
Davidson K, Clare AW (1989) Psychotic illness following termination of pregnancy. Br J Psychiatry 154:559–560
Khandheria M, Snook E, Thomas C (2014) Psychotic episode secondary to metronidazole use. Gen Hosp Psychiatry 36(2):231 e3–e4
Schreiber W, Spernal J (1997) Metronidazole-induced psychotic disorder. Am J Psychiatry 154(8):1170–1171
Uhl MD, Riely CA (1996) Metronidazole in treating portosystemic encephalopathy. Ann Intern Med 124(4):455
Zahiruddin O, Shanooha M, Mohd MY, Azhar (2014) Psychosis induced by cefuroxime and metronidazole. Med J Malaysia 69(1):33–34
Lamp KC et al (1999) Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials. Clin Pharmacokinet 36(5):353–373
Nau R, Sorgel F, Eiffert H (2010) Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev 23(4):858–883
Cavanagh JB (1988) Lesion localisation: implications for the study of functional effects and mechanisms of action. Toxicology 49(1):131–136
Rogulja Pv, Kovac W, Schmid H (1973) Metronidazol-encephalopathie der ratte. Acta Neuropathol 25(1):36–45
Alston TA, Abeles RH (1987) Enzymatic conversion of the antibiotic metronidazole to an analog of thiamine. Arch Biochem Biophys 257(2):357–362
Zuccoli G, Pipitone N (2009) Neuroimaging findings in acute Wernicke’s encephalopathy: review of the literature. AJR Am J Roentgenol 192(2):501–508
Zuccoli G et al (2009) MR imaging findings in 56 patients with Wernicke encephalopathy: nonalcoholics may differ from alcoholics. AJNR Am J Neuroradiol 30(1):171–176
Evans J et al (2003) Diazepam as a treatment for metronidazole toxicosis in dogs: a retrospective study of 21 cases. J Vet Intern Med 17(3):304–310
Bradley WG, Karlsson IJ, Rassol CG (1977) Metronidazole neuropathy. Br Med J 2(6087):610–611
Rao DN, Mason RP (1987) Generation of nitro radical anions of some 5-nitrofurans, 2- and 5-nitroimidazoles by norepinephrine, dopamine, and serotonin. A possible mechanism for neurotoxicity caused by nitroheterocyclic drugs. J Biol Chem 262(24):11731–11736
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
All authors declare that they have no conflicts of interest.
Ethical standards
Patient data in this review have previously been published with consent in accordance with the ethical standards in the Declaration of Helsinki.
Informed Consent
Patient consent was obtained for the images shown in Fig. 4.
Electronic supplementary material
Below is the link to the electronic supplementary material.
415_2018_9147_MOESM1_ESM.xlsx
Results of the systematic literature search including clinical data on identified cases of metronidazole-induced encephalopathy (XLSX 29 KB)
Rights and permissions
About this article
Cite this article
Sørensen, C.G., Karlsson, W.K., Amin, F.M. et al. Metronidazole-induced encephalopathy: a systematic review. J Neurol 267, 1–13 (2020). https://doi.org/10.1007/s00415-018-9147-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-018-9147-6